Lensar today entered into a priority credit line agreement in a move that analysts say casts doubt over its planned acquisition by Alcon.

Lensar (Nasdaq:LNSR) announced today that it reached an agreement with Alcon (NYSE:ALC) to terminate their planned merger.

Swiss-American eye care firm Alcon Inc (NYSE:ALC) stock slumped on Wednesday after the company cut its 2025 outlook late on Tuesday, citing increased tariff impact. The company forecasts a full-year ...

Investing.com -- UBS reiterated a “buy” rating on Alcon Inc on Wednesday, naming the Swiss-headquartered eyecare company its top large-cap pick and setting a CHF95 price target, implying more than 50% ...

ZURICH (Reuters) - Novartis's spinoff of its eyecare division Alcon, set for Tuesday April 9, marks the largest Swiss stock deal in a decade and forces a reshuffle of the benchmark Swiss Market Index ...

Alcon (ALC) received its lone sell-equivalent rating on Wall Street as Bank of America downgraded the Swiss eye care company to Underperform from Buy on Thursday, arguing that consensus estimates are ...